GO
Loading...

Spain

More

  • *Mood swing from austerity seen helping France's case. PARIS, Sept 30- From Athens to Madrid and Dublin to Rome, France can count on a sympathetic hearing in several European capitals in its campaign for leniency over the latest broken promise to bring its public finances into shape.

  • MADRID, Sept 30- A raft of new cancer drugs promise better, longer-lasting treatments with fewer adverse side effects-- but their high cost is a growing concern. Price-- just as much as safety and efficacy-- has proved a hot topic for nearly 20,000 oncology experts at the European Society for Medical Oncology annual congress in Madrid.

  • MADRID, Sept 29- Spain's Constitutional Court suspended on Monday an independence referendum called by Catalonia for November, although political forces in the wealthy north-east region forged ahead with a political campaign ahead of their planned vote.

  • LONDON, Sept 29- Greek government bond yields rose to their highest in almost two months on Monday as Athens' plans for an early exit from a bailout programme raised concerns about future financing and debt relief.

  • TORONTO, Sept 29- Even as BlackBerry pivots to focus more on software and services, the company that gained fame for its smartphones is not giving up on its handset business, two senior executives said.

  • Bubble bubble, toil and global troubles hit stocks Monday, 29 Sep 2014 | 9:57 AM ET
    Riot police use pepper spray as they clash with protesters, as tens of thousands of protesters block the main street to the financial Central district outside the government headquarters in Hong Kong September 28, 2014.

    Brazil, Hong Kong, Spain —take your pick. International uncertainty abounds, and it's spilling over into U.S. markets.

  • By Barbara Lewis and Adrian Croft. BRUSSELS, Sept 29- European Union regulators will provide more details on Tuesday of their reasons for launching in-depth inquiries into tax arrangements reached by Ireland with Apple and by Luxembourg with a Fiat subsidiary.

  • *Roche set to compete with established GSK combination. *Shares in Roche's biotech partner Exelixis jump 20 pct. MADRID, Sept 29- Rival two-pill combinations for melanoma from Roche and GlaxoSmithKline had similarly good results in separate clinical trials, leaving doctors with little to choose between the two skin cancer courses.

  • *Perjeta builds on Roche's strong position in breast cancer. MADRID, Sept 28- A new breast cancer drug from Roche has shown "unprecedented" benefits in extending lives in a clinical trial and experts urged its widespread use for women with an aggressive form of the disease.

  • MADRID, Sept 28- Merck& Co's drug Keytruda, the first in a new wave of immune-boosting medicines to be approved for treating melanomas in the United States, also has potential in stomach cancer, new research shows.

  • MADRID- ROCHE'S PERJETA DRUG ADDS 15.7 MONTHS SURVIVAL BENEFIT IN METASTATIC BREAST CANCER STUDY.

  • *Perjeta builds on Roche's strong position in breast cancer. MADRID, Sept 28- A new breast cancer drug from Roche has shown "unprecedented" survival benefits in a clinical trial, boosting prospects for its widespread use in women with an aggressive form of the disease.

  • MADRID/ SYDNEY, Sept 28- A year after Spain, the sunniest country in Europe, issued notice of a law forcing solar energy-equipped homes and offices to pay a punitive tax, architect Inaki Alonso re-installed a 250 watt solar panel on a beam over his Madrid roof terrace.

  • *AstraZeneca says tolerability profile encouraging. MADRID, Sept 27- Early results for a closely watched cancer drug combination from AstraZeneca that boosts the immune system show the cocktail is promising, though limited patient numbers mean the data is far from conclusive.

  • Sept 27- Pfizer Inc's Xalkori, which treats lung cancer patients with a specific gene mutation, proved effective in shrinking tumors in those with an even rarer form of the disease, according to data presented at a medical meeting on Saturday.

  • *AstraZeneca says tolerability profile encouraging. MADRID, Sept 27- Early results for a closely watched cancer drug combination from AstraZeneca that boosts the immune system suggest the cocktail is promising, though limited patient numbers mean the data is far from conclusive.

  • Catalonia defies Spain by calling secession vote Saturday, 27 Sep 2014 | 4:42 AM ET

    BARCELONA, Spain— The president of Spain's powerful northeastern region of Catalonia on Saturday formally called an independence referendum, the latest secession push in Europe and one of the most serious challenges to the Spanish state of recent years.

  • *Spain lifts 2014 GDP forecast to 1.3 pct from 1.2 pct. MADRID, Sept 26- Spain on Friday raised its forecast for economic growth this year and next, in contrast with countries like Italy and France that are lowering their outlook.

  • European stocks hit by news of Gross departure Friday, 26 Sep 2014 | 10:25 AM ET

    *Allianz tumbles 6 pct as Gross leaves Pimco. PARIS, Sept 26- European shares trimmed gains in afternoon trade as shares of German insurer Allianz plunged on news that fund manager Bill Gross was leaving Allianz's asset-management unit Pimco.

  • Spain hopes to create 622,000 jobs by end of 2015 Friday, 26 Sep 2014 | 9:40 AM ET

    MADRID— Spain expects a six-year run of job destruction will end next year, when it predicts 622,000 jobs to be created. That would mean some 5 million would still be jobless, roughly the same number as when the Popular Party took office late 2011.. Spain fell into the first of two recessions in the second half of 2008. It emerged from the second slump late 2013..